FAIROTC · Healthcare

InnoCare Pharma Limited

INCPF

FAIR PRICE VALUATION

8.4%fair value

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$1.55

FAIR PRICE

$1.42

MARGIN

$0.13

UNDERVALUEDFAIROVERVALUED

P/E Ratio

29.1x

What is P/E? →

Div. Yield

N/A

ROE

12.0%

Average

Market Cap

$16B

Large-cap

COMING SOON

Get notified when INCPF's fair price changes

Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.

iOS and Android · Free tier available

KEY FACTS

CEO

Jisong Cui

COUNTRY

CN

HEADQUARTERS

Beijing

SECTOR

Healthcare

EXCHANGE

OTC

METHODOLOGY

How we calculate INCPF's fair price

InnoCare Pharma Limited's fair price of $1.42 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $1.55, INCPF trades 8.4% above its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting INCPF's risk profile.

RELATIVE · 30%

Comparing INCPF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for INCPF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate INCPF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for INCPF.

Explore on Bulios

FAQ

What is the fair price of INCPF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for InnoCare Pharma Limited is $1.42. At the current market price of $1.55, INCPF trades 8.4% above its calculated fair value.

Is INCPF overvalued or undervalued?+

InnoCare Pharma Limited is currently fair based on our valuation model. The stock trades at $1.55, which is 8.4% above the fair price of $1.42. The P/E ratio of 29.1x is a key metric in the valuation.

How often is INCPF's fair price updated?+

We update fair price calculations for INCPF daily after market close. The current fair price of $1.42 incorporates the latest market data and sector multiples.

What factors affect INCPF's fair price calculation?+

INCPF's fair price of $1.42 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 29.1x, ROE of 12.0%.

Is INCPF a good buy right now?+

At $1.55, INCPF trades 8.4% above our fair value estimate of $1.42. The stock is currently fair. ROE stands at 12.0% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does INCPF pay dividends?+

INCPF does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.